The following APIs were added: 

The 1st Invitation to manufacturers of medicinal products for treatment of substance use disorders to submit an application for product evaluation by prequalification has been issued based on a req

The Invitation to Manufacturers of human insulin and insulin analogues was recently updated and renamed as Invitation to Manufacturers of medicinal products for management of diabetes to Submit an

Amodiaquine (hydrochloride) manufactured by Anuh Pharma Ltd. has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.

WHOAPI-431 (Albendazole) manufactured by Rakshit Drugs Private Limited has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.

WHO has prequalified the cobas® MTB‑RIF/INH assay, confirming its compliance with international quality, safety, and performance requirements under the WHO Prequalification progra

A training for assessors is being conducted at the WHO Academy in Lyon from 21 to 24 April 2026 to strengthen capacity for the WHO prequalification of in vitro diagnostics (IVDs).

The cobas® MTB test by Roche Diagnostics has been added to the WHO Prequalification list, supporting access to quality‑assured molecular tuberculosis diagnostics.